Log in or Sign up for Free to view tailored content for your specialty!
CHD/Prevention News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
Breast arterial calcification seen on routine mammograms, especially among younger women, is associated with increased risk for death and adverse cardiovascular outcomes, including heart failure, myocardial infarction and stroke, data show.
Elevated CVD risk with type 2 diabetes may be traceable to diabetes development factors
People with type 2 diabetes had twice the number of CVD events vs. matched counterparts, with events starting 3 decades before diagnosis, suggesting their elevated CVD risk may be attributable to factors tied to diabetes development.
Log in or Sign up for Free to view tailored content for your specialty!
Obicetrapib tied to sizable LDL lowering on top of other therapies in high-risk patients
CHICAGO — In patients with heterozygous familial hypercholesterolemia with high LDL despite being on optimal medical therapy, obicetrapib greatly lowered LDL levels compared with placebo, according to the results of the BROOKLYN trial.
ESSENCE: Semaglutide bests placebo in MASH resolution, fibrosis improvement at 72 weeks
SAN DIEGO — Semaglutide was superior to placebo in metabolic dysfunction-associated steatohepatitis resolution and improvement in fibrosis at 72 weeks, with a safety profile consistent with previous studies, according to late-breaking data.
Mediterranean-style diet may reduce adverse pregnancy outcomes for Black, Hispanic women
CHICAGO — Black and Hispanic women who adhered to components of a Mediterranean-style diet were less likely to experience any adverse pregnancy outcome, regardless of overweight or obesity status, researchers reported.
Salt substitution at age 40 years cost-effective for high-risk adults with prehypertension
Salt substitution intervention beginning at age 40 years was cost-effective among Chinese adults with prehypertension compared with antihypertensive drug treatment alone, according to findings published in Hypertension.
Semaglutide could be ‘practice changing’ for adults with diabetes, CKD
The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, but it could also lead to changes in the way clinicians treat the condition.
First investigational oral therapy lowers Lp(a) in phase 2 study
CHICAGO — Adults with elevated liproprotein(a) at high risk for a CV event saw substantial reductions over 12 weeks with muvalaplin, an investigational oral small molecule Lp(a) inhibitor, data from a phase 2 study show.
Food access in formerly redlined neighborhoods tied to poor cardiometabolic health
CHICAGO — People living in historically redlined neighborhoods with poor access to healthy foods were more likely to have type 2 diabetes, hypertension, coronary heart disease and obesity, researchers reported.
Email ‘nudges’ highlighting flu vaccine’s heart benefits improve uptake
CHICAGO — Emailed messages emphasizing the CV benefits of influenza vaccination improved vaccine uptake among older and younger adults in Denmark, particularly among more vulnerable patients with a history of acute MI, researchers reported.
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read